Julian Schulze Zur Wiesch to HIV Integrase Inhibitors
This is a "connection" page, showing publications Julian Schulze Zur Wiesch has written about HIV Integrase Inhibitors.
Connection Strength
0.687
-
Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients. Medicine (Baltimore). 2019 Aug; 98(32):e16721.
Score: 0.687